Latest Articles
Childhood trauma may increase the risk of endometriosis | Faculty of Medicine | UiB - Universitetet i Bergen
Childhood trauma may increase the risk of endometriosis | Faculty of Medicine | UiB Universitetet i Bergen
Published: Feb. 6, 2025, 9:58 a.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Yahoo! Voices
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Yahoo! Voices
Published: Feb. 6, 2025, 9:54 a.m.
Who was Shirley Beiger, and was she innocent or guilty? - The Australian Women's Weekly
Who was Shirley Beiger, and was she innocent or guilty? The Australian Women's Weekly
Published: Feb. 6, 2025, 6:06 a.m.
Real world perspectives on endometriosis disease phenotyping through surgery, omics, health data, and artificial intelligence - Nature.com
Real world perspectives on endometriosis disease phenotyping through surgery, omics, health data, and artificial intelligence Nature.com
Published: Feb. 6, 2025, 5 a.m.
Healthy Living Ask the Expert: Gynecologist explains endometriosis - VOA Africa
Healthy Living Ask the Expert: Gynecologist explains endometriosis VOA Africa
Published: Feb. 6, 2025, 4 a.m.
The weaponization of predictive data analytics, red flags, and the chronic pain gender gap has become a radioactive crisis in U.S. health care - Kevin MD
The weaponization of predictive data analytics, red flags, and the chronic pain gender gap has become a radioactive crisis in U.S. health care Kevin MD
Published: Feb. 5, 2025, 8:06 p.m.
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? - Medpage Today
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? Medpage Today
Published: Feb. 5, 2025, 7:31 p.m.
New evidence on the association between endometriosis and traumatic and stressful experiences - Universitat de Barcelona
New evidence on the association between endometriosis and traumatic and stressful experiences Universitat de Barcelona
Published: Feb. 5, 2025, 6:50 p.m.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today
Published: Feb. 5, 2025, 5:54 p.m.
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive
Published: Feb. 5, 2025, 5:17 p.m.
Link copied to clipboard!